Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

NCT06203821 is registered in ClinicalTrials.gov with Aram Hezel as lead sponsor.

NCT NCT06203821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06203821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Lead sponsor
Aram Hezel
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 30, 2032
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer